Rafael Holdings

Rafael Holdings, Inc., founded as a US-based holding company, specializes in real estate development and cancer therapeutics. The company's core mission is to develop novel cancer and immune therapies that address high unmet medical needs. Rafael Holdings is a significant investor in two clinical-stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd. The company also seeks opportunities to invest in, acquire, or in-license additional therapeutic assets.

Notable affiliated people include the leadership teams of Cornerstone Pharmaceuticals and LipoMedix Pharmaceuticals, who are key to advancing the company's oncology initiatives. Rafael Holdings' key achievements include substantial investments in promising cancer therapeutics that have the potential to improve and extend patients' lives. The overall impact of Rafael Holdings lies in its dual focus on real estate and innovative cancer treatments, aiming to make significant contributions to both fields.